When Brunde Broady's infant son experienced an onslaught of health issues that conventional medicine could neither define nor treat, she began her own research-based quest for answers. Over the course of ten years, she pulled together hundreds of threads from scientific journal articles and revealed the importance of the enzyme Calcium ATPase. Broady has a Yale MBA and has received patents in both the United States and China related to her work on Calcium ATPase. Her goal is to share her knowledge with as many people as possible to help them make educated health and lifestyle decisions. Russell Dahl has co-authored over eighty scientific publications and is an inventor with over fifty patent applications. He is a former Professor of Neuroscience and Medicinal Chemistry and received his PhD in organic chemistry from the University of California, San Diego as a DuPont pharmaceuticals fellow and has additional training in molecular pharmacology from Stanford University. Russell is the CEO and scientific founder of Neurodon. Previously, he led all small molecule research at Celladon, where he was responsible for progressing a diverse small molecule pipeline into the clinic.
